Michael Ambrogi
2017
In 2017, Michael Ambrogi earned a total compensation of $2.3M as Chief Operating Officer at NovoCure, a 225% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $956,685 |
| Salary | $381,225 |
| Stock Awards | $669,240 |
| Other | $13,200 |
| Total | $2,254,350 |
Ambrogi received $956.7K in option awards, accounting for 42% of the total pay in 2017.
Ambrogi also received $234K in non-equity incentive plan, $381.2K in salary, $669.2K in stock awards and $13.2K in other compensation.
Rankings
In 2017, Michael Ambrogi's compensation ranked 4,930th out of 14,666 executives tracked by ExecPay. In other words, Ambrogi earned more than 66.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,930 out of 14,666 | 66th |
Division Manufacturing | 1,753 out of 5,770 | 70th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 242 out of 856 | 72nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 126 out of 528 | 76th |
Industry Surgical and Medical Instruments and Apparatus | 77 out of 333 | 77th |
Source: SEC filing on April 20, 2018.
Ambrogi's colleagues
We found four more compensation records of executives who worked with Michael Ambrogi at NovoCure in 2017.